GGrantIndex
← Leaderboards

Kyrana Tsapkini

Johns Hopkins University

$13,773,256
Attributed
$16,531,464
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY201525
$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,531,464 · 4

By mechanism

R01$16,531,464 · 4

Top collaborators

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposRestPrimary Progressive AphasiaAreaNamesAffectLeftNeurodegenerative DisordersPerformanceBrainLanguageS DiseaseLanguage DisordersEffective TherapyNeuroregulationCharacteristicsAftercareAphasiaVariantOralCognitiveDouble-Blind MethodLanguage TherapyBehavior Therapy

Grant awards (21)

Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia$1,075,653
R01 · FY2025 · AG
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic AD$740,584
R01 · FY2025 · AG · contact PI
Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia$241,630
R01 · FY2025 · AG
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic AD$31,360
R01 · FY2025 · AG · contact PI
Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia$1,349,116
R01 · FY2024 · AG
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic AD$781,622
R01 · FY2024 · AG · contact PI
Transcranial direct current stimulation in typical and atypical Alzheimer's disease$737,719
R01 · FY2024 · AG · contact PI
Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia$1,349,116
R01 · FY2023 · AG
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic AD$801,547
R01 · FY2023 · AG · contact PI
Transcranial direct current stimulation in typical and atypical Alzheimer's disease$747,544
R01 · FY2023 · AG · contact PI
Phase II clinical trial of transcranial direct current stimulation in the treatment of primary progressive aphasia$1,500,901
R01 · FY2022 · AG
Targeting language-specific and executive-control networks with transcranial direct current stimulation in aphasic AD$828,275
R01 · FY2022 · AG · contact PI
Transcranial direct current stimulation in typical and atypical Alzheimer's disease$753,120
R01 · FY2022 · AG · contact PI
Transcranial direct current stimulation in typical and atypical Alzheimer's disease$759,034
R01 · FY2021 · AG · contact PI
Transcranial direct current stimulation in typical and atypical Alzheimer's disease$781,365
R01 · FY2020 · AG · contact PI
Effects of tDCS on spoken and written production in Primary Progressive Aphasia$683,555
R01 · FY2019 · DC · contact PI
Effects of tDCS on spoken and written production in Primary Progressive Aphasia$720,986
R01 · FY2018 · DC · contact PI
Effects of transcranial direct current stimulation in spoken and written production in primary progressive aphasia$387,554
R01 · FY2018 · DC · contact PI
Effects of tDCS on spoken and written production in Primary Progressive Aphasia$739,796
R01 · FY2017 · DC · contact PI
Effects of tDCS on spoken and written production in Primary Progressive Aphasia$752,315
R01 · FY2016 · DC · contact PI
Effects of tDCS on spoken and written production in Primary Progressive Aphasia$768,672
R01 · FY2015 · DC · contact PI